超声造影在胸膜下肺部病变的临床应用价值
Clinical Value of Contrast-Enhanced Ultrasonography in Subpleural Pulmonary Lesions
摘要: 胸膜下肺部病变一直以来主要依靠X线、CT、纤维支气管镜和PET-CT的诊断，在超声方面的应用不多。一方面是因为不是所有的肺部病变超声都能显示，超声只能观察到一些胸膜下的肺部病变；另一方面是因为大部分肺部病变在常规超声上的表现都较为类似。但随着超声造影剂的出现，其能够很好地显示实质脏器及其病变内的血管灌注情况，已经广泛应用于各个脏器，尤其是在肝脏及乳腺的使用，但在胸膜下肺部病变的应用及研究还不是很多，在此本文对目前国内外学者的研究成果作一整理，着重阐述超声造影在胸膜下肺部病变的临床应用价值。
Abstract: Subpleural pulmonary lesions have always been diagnosed mainly by X-ray, CT, fiberoptic bronchoscope and PET-CT, but they are seldom used in ultrasound. On the one hand, not all lung lesions can be displayed by ultrasound, and only some subpleural lung lesions can be observed by ultrasound; on the other hand, most lung lesions are similar in ultrasound performance, but with the emergence of ultrasound contrast agents, it can well display the vascular perfusion in parenchymal organs and their lesions, and has been widely used in various organs, especially in liver and breast, but there are not many applications and researches in lung lesions. Here, we will sort out the research results of scholars at home and abroad, and emphasize the clinical application value of enhanced ultrasound in subpleural pulmonary lesions.
文章引用：常艺, 王胜利, 周晓莹, 白宝艳. 超声造影在胸膜下肺部病变的临床应用价值[J]. 临床医学进展, 2022, 12(1): 319-324. https://doi.org/10.12677/ACM.2022.121048

参考文献

[1] 陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13.
[2] 刘亚芳, 邢舴, 宋勇. 不同途径获取肺癌组织对病理类型诊断的差异性分析[J]. 医学研究生学报, 2016, 29(5): 500-503.
[3] Correas, J.M., Birdal, L., Lesavre, A., et al. (2001) Ultrasound Contrast Agents; Properties, Principles of Action, Tolerance, and Artifacts. European Radiology, 11, 1316-1328. [Google Scholar] [CrossRef] [PubMed]
[4] 黄朝旭, 施仲伟. 超声微泡造影剂的安全性研究[J]. 国际心血管病杂志, 2010, 37(3): 155-157.
[5] Chong, W.K., Papadopoulou, V. and Dayton, P.A. (2018) Imaging with Ultrasound Contrast Agents: Current Status and Future. Abdominal Radiology (NY), 43, 762-772. [Google Scholar] [CrossRef] [PubMed]
[6] Gorg, C., Bert, T. and Kring, R. (2006) Contrast-Enhanced Sonography of the Lung for Differential Diagnosis of Atelectasis. Journal of Ultrasound in Medicine, 25, 35-39. [Google Scholar] [CrossRef] [PubMed]
[7] Eldridge, L. and Wagner, E.M. (2019) Angiogenesis in the Lung. The Journal of Physiology, 597, 1023-1032. [Google Scholar] [CrossRef] 
[8] Zhang, H.-X., et al. (2016) A New Method for Discriminating between Bronchial and Pulmonary Arterial Phases Using Contrast-Enhanced Ultrasound. Ultrasound in Medicine & Biology, 42, 1441-1449. [Google Scholar] [CrossRef] [PubMed]
[9] Shen, M., Bi, K., Cong, Y., et al. (2021) Application of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Benign and Malignant Subpleural Pulmonary Lesions. Journal of Ultrasound in Medicine. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, S., Yang, W., Fu, J.J., et al. (2016) Microflow Imaging of Contrast-Enhanced Ultrasound for Evaluation of Neovascularization in Peripheral Lung Cancer. Medicine (Baltimore), 95, e4361. [Google Scholar] [CrossRef] 
[11] Sidhu, P.S., Cantisani, V., Dietrich, C.F., et al. (2018) The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultra-Sound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall in der Medizin, 39, e2-e44.
[12] Bai, J., Yang, W., Wang, S., Guan, R.H., Zhang, H., Fu, J.J., Wu, W. and Yan, K. (2016) Role of Arrival Time Difference between Lesions and Lung Tissue on Contrast-Enhanced Sonography in the Differential Diagnosis of Subpleural Pulmonary Lesions. Journal of Ultrasound in Medicine, 35, 1523-1532. [Google Scholar] [CrossRef] [PubMed]
[13] Tang, M., Xie, Q., Wang, J., et al. (2020) Time Difference of Arrival on Contrast-Enhanced Ultrasound in Distinguishing Benign Inflammation from Malignant Peripheral Pulmonary Lesions. Frontiers in Oncology, 12, Article ID: 578884. [Google Scholar] [CrossRef] [PubMed]
[14] Bi, K., Zhou, R.R., Zhang, Y., et al. (2021) US Contrast Agent Arrival Time Difference Ratio for Benign versus Malignant Subpleural Pulmonary Lesions. Radiology, 301, 200-210. [Google Scholar] [CrossRef] [PubMed]
[15] Görg, C. (2007) Transcutaneous Contrast-Enhanced Sonography of Pleural-Based Pulmonary Lesions. European Journal of Radiology, 64, 213-221. [Google Scholar] [CrossRef] [PubMed]
[16] 唐敏, 宋建琼, 郑小雪, 等. 富血供肺周围型病变的超声造影实时分析[J]. 中国超声医学杂志, 2019, 35(9): 776-779.
[17] Dong, Y., Mao, F., Wang, W.P., et al. (2015) Value of Contrast-Enhanced Ultrasound in Guidance of Percutaneous Biopsy in Peripheral Pulmonary Lesions. BioMed Research International, 2015, Article ID: 531507. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, S., Yang, W., Zhang, H., et al. (2015) The Role of Contrast-Enhanced Ultrasound in Selection Indication and Improveing Diagnosis for Transthoracic Biopsy in Peripheral Pulmonary and Mediastinal Lesions. BioMed Research International, 2015, Article ID: 231782. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Y., Xu, Z., Huang, H., et al. (2020) Application of Quantitative Contrast-Enhanced Ultrasound for Evaluation and Guiding Biopsy of Peripheral Pulmonary Lesions: A Preliminary Study. Clinical Radiology, 5, 79.e19-79. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, H., Guang, Y., He, W., et al. (2020) Ultrasound-Guided Percutaneous Needle Biopsy Skill for Peripheral Lung Lesions and Complications Prevention. The Journal of Thoracic Disease, 12, 3697-3705. [Google Scholar] [CrossRef] [PubMed]
[21] Lei, Z., Lou, J., Bao, L. and Lv, Z. (2018) Contrast-Enhanced Ultrasound for Needle Biopsy of Central Lung Cancer with Atelectasis. Journal of Medical Ultrasonics, 45, 461-467. [Google Scholar] [CrossRef] [PubMed]
[22] Yuan, X., Zhang, J., Ao, G., et al. (2012) Lung Cancer Perfusion: Can We Measure Pulmonary and Bronchial Circulation Simultaneously? European Radiology, 22, 1665-1671. [Google Scholar] [CrossRef] [PubMed]
[23] Findeisen, H., Trenker, C., Figiel, J., et al. (2019) Vascularization of Primary, Peripheral Lung Carcinoma in CEUS—A Retrospective Study (n = 89 Patients). Ultraschall in der Medizin, 40, 603-608. [Google Scholar] [CrossRef] [PubMed]
[24] Tian, Y., Liu, Z., Tan, H., et al. (2020) New Aspects of Ultrasound-Mediated Targeted Delivery and Therapy for Cancer. International Journal of Nanomedicine, 15, 401-418. [Google Scholar] [CrossRef] 
[25] Meng, L., Yuan, S., Zhu, L., et al. (2019) Ultrasound-Microbubbles-Mediated microRNA-449a Inhibits Lung Cancer Cell Growth via the Regulation of Notch1. OncoTargets and Therapy, 12, 7437-7450. [Google Scholar] [CrossRef] 
[26] Ren, H., An, C., Liang, P., et al. (2019) Ultrasound-Guided Percutaneous Microwave Ablation Assisted by Athree-Dimensional Visualization Treatment Platform Combined with Transcatheter Arterial Chemoembolization for a Single Large Hepatocellular Carcinoma 5 cm or Larger: A Preliminary Clinical Application. International Journal of Hyperthermia, 36, 44-54. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, F., Liu, D., Wang, K., et al. (2020) Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients. Liver Cancer, 9, 397-413. [Google Scholar] [CrossRef] [PubMed]
[28] Hu, H.T., Wang, W., Chen, L.D., et al. (2021) Artificial Intelligence Assists Identifying Malignant versus Benign Liver Lesions Using Contrast-Enhanced Ultrasound. Journal of Gastroenterology and Hepatology, 36, 2875-2883. [Google Scholar] [CrossRef] [PubMed]

为你推荐